Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Calcium × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

pembrolizumab 78 Carboplatin 64 Cisplatin 61 Paclitaxel 51 Specimen Handling 49 Magnetic Resonance Spectroscopy 47 Gemcitabine 45 Docetaxel 36 Cyclophosphamide 35 Pemetrexed 32 Dexamethasone 31 Fluorouracil 30 Bevacizumab 30 Doxorubicin 29 Radiotherapy 28 Capecitabine 28 Oxaliplatin 27 durvalumab 26 Radiation 26 Rituximab 24 Leucovorin 24 Lenalidomide 23 Vincristine 21 130-nm albumin-bound paclitaxel 18 Prednisone 17 Nivolumab 17 Irinotecan 17 venetoclax 16 Taxes 16 Trastuzumab 15

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01480869 2026-03-12

VITACAL

Institut du Cancer de Montpellier - Val d'Aurelle

Phase 3 Completed

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡